Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 4
2012 3
2013 2
2016 1
2017 2
2019 4
2020 4
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Free article. Clinical Trial.
Leptin, Both Bad and Good Actor in Cancer.
Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, Pérez-Pérez A, Castiñeiras J, Virizuela-Echaburu JA, de la Cruz-Merino L, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Among authors: virizuela echaburu ja. Biomolecules. 2021 Jun 20;11(6):913. doi: 10.3390/biom11060913. Biomolecules. 2021. PMID: 34202969 Free PMC article. Review.
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations.
López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P, Velasco Del Castillo S, López de Sá Areses E, Barreiro-Pérez M, Hinojar Baydes R, Pérez de Isla L, Valbuena López SC, Dalmau González-Gallarza R, Calvo-Iglesias F, González Ferrer JJ, Castro Fernández A, González-Caballero E, Mitroi C, Arenas M, Virizuela Echaburu JA, Marco Vera P, Íñiguez Romo A, Zamorano JL, Plana Gómez JC, López Sendón Henchel JL. López-Fernández T, et al. Among authors: virizuela echaburu ja. Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):474-486. doi: 10.1016/j.rec.2016.12.041. Epub 2017 Mar 18. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28330818 Review. English, Spanish.
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations.
López-Fernández T, Martín-García A, Roldán Rabadán I, Mitroi C, Mazón Ramos P, Díez-Villanueva P, Escobar Cervantes C, Alonso Martín C, Alonso Salinas GL, Arenas M, Arrarte Esteban VI, Ayala de La Peña F, Castro Fernández A, García Pardo H, García-Sanz R, González Porras JR, López de Sá E, Lozano T, Marco Vera P, Martínez Marín V, Mesa Rubio D, Montero Á, Oristrell G, Pérez de Prado A, Velasco Del Castillo S, Virizuela Echaburu JA, Zatarain-Nicolás E, Anguita Sánchez M, Tamargo Menéndez J; Expert reviewers. López-Fernández T, et al. Among authors: virizuela echaburu ja. Rev Esp Cardiol (Engl Ed). 2019 Sep;72(9):749-759. doi: 10.1016/j.rec.2019.03.019. Epub 2019 Aug 9. Rev Esp Cardiol (Engl Ed). 2019. PMID: 31405794 Review. English, Spanish.
The burden of rare cancers in Europe.
Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. Gatta G, et al. Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Adv Exp Med Biol. 2010. PMID: 20824452 Review.
Current functioning of cardio-oncology units in Spain.
Mitroi C, Martín-García A, Mazón Ramos P, Virizuela Echaburu JA, Arenas-Prat M, García-Sanz R, Arrarte Esteban V, García-Pinilla JM, Cosín-Sales J, López-Fernández T. Mitroi C, et al. Among authors: virizuela echaburu ja. Clin Transl Oncol. 2020 Aug;22(8):1418-1422. doi: 10.1007/s12094-019-02250-4. Epub 2019 Dec 20. Clin Transl Oncol. 2020. PMID: 31863353
Gastrointestinal stromal tumors: morphological, immunohistochemical and molecular changes associated with kinase inhibitor therapy.
Díaz Delgado M, Hernández Amate A, Pereira Gallardo S, Jaramillo S, Virizuela Echaburu JA, González-Cámpora RJ. Díaz Delgado M, et al. Among authors: virizuela echaburu ja. Pathol Oncol Res. 2011 Sep;17(3):455-61. doi: 10.1007/s12253-011-9362-2. Epub 2011 Jan 29. Pathol Oncol Res. 2011. PMID: 21279555 Free article. Review.
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel.
Herrero Rivera D, Vacas CG, Kovandzic LM, Vázquez JP, Alonso LA, González BM, Aragón VC, Grande E, Caro RL, Virizuela Echaburu JA, Rodríguez Moreno JF, Etxebarria AA, Rodríguez-Antona C, Durán I. Herrero Rivera D, et al. Among authors: virizuela echaburu ja. Pharmacogenomics. 2022 Jul;23(11):627-638. doi: 10.2217/pgs-2022-0023. Epub 2022 Jul 26. Pharmacogenomics. 2022. PMID: 35880554
21 results